4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001415889-24-021452
Chief Medical Officer sold 2,000 shares at $40.00 ($80,000)
- Chief Medical Officer acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lizzul Paul F. · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,000 | $18.50 | $37,000 | 13,618 | D |
| 2024-08-14 | Sale : show line 2 in the form 10b5-1 | −2,000 | $40.00 | $80,000 | 11,618 | D |
| Open-market sales · 2,000 sh · avg $40.00 · $80,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-14 | Exercise or conversion : show line 3 in the form 10b5-1 Common | −2,000 | 86,500 | D |
Loading xslF345X05/form4-08162024_080835.xml…